Y-MABS THERAPEUTICS INC. - COMMON STOCK
10.41
22-نوفمبر-24 15:44:58
15 متأخرة بدقائق
الأسهم
+0.31
+3.07%
نطاق اليوم
9.93 - 10.49
ISIN
N/A
المصدر
NASDAQ
-
Y-mAbs’ Announces Clearance of IND for GD2-SADA
12 يوليو 2022 08:00:02 بحسب Nasdaq GlobeNewswire
-
31 مايو 2022 08:00:01 بحسب Nasdaq GlobeNewswire
-
26 مايو 2022 15:01:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces First Quarter Financial Results and Recent Corporate Developments
09 مايو 2022 15:01:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs to Announce First Quarter 2022 Financial and Operating Results on May 9, 2022
03 مايو 2022 15:01:00 بحسب Nasdaq GlobeNewswire
-
27 أبريل 2022 15:01:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Presentation of SADA Technology at AACR
08 أبريل 2022 08:00:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Submission of Omburtamab Biologics License Application to FDA
01 أبريل 2022 08:00:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Reports Fourth Quarter and Full Year 2021 Financial Results and Recent Corporate Developments
24 فبراير 2022 15:01:01 بحسب Nasdaq GlobeNewswire
-
Y-mAbs to Announce 2021 Financial and Operating Results on February 24, 2022
17 فبراير 2022 08:00:01 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Completion of Pre-BLA Meeting with FDA for Omburtamab
11 فبراير 2022 08:00:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Therapeutics to Present at 40th Annual J.P. Morgan Healthcare Conference
05 يناير 2022 08:00:01 بحسب Nasdaq GlobeNewswire
-
UPDATE - Y-mAbs Announces Pipeline Update
15 ديسمبر 2021 08:53:41 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Pipeline Update
15 ديسمبر 2021 08:00:02 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Hosting Virtual Research and Development Day
06 ديسمبر 2021 15:05:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Third Quarter Financial Results and Recent Corporate Developments
04 نوفمبر 2021 15:05:01 بحسب Nasdaq GlobeNewswire
-
04 نوفمبر 2021 08:00:02 بحسب Nasdaq GlobeNewswire
-
Y-mAbs to Announce Third 2021 Financial and Operating Results on November 4, 2021
28 أكتوبر 2021 15:01:00 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Data to be Presented at SIOP 2021
16 سبتمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire
-
Y-mAbs Announces Priority Review of BLA for DANYELZA® (naxitamab-gqgk) in China
13 سبتمبر 2021 08:00:01 بحسب Nasdaq GlobeNewswire